Literature DB >> 22773799

Exocrine pancreas cancer and thromboembolic events: a systematic literature review.

Andrew S Epstein1, Eileen M O'Reilly.   

Abstract

Exocrine pancreas cancer continues to represent a significant therapeutic challenge, with high rates of mortality and morbidity, including from thromboembolic events, which have long been described as a frequent complication of the disease. This article provides a systematic and comprehensive review of the literature to address the clinical and pathologic features recognized in pancreas cancer pertaining to thrombosis, and to discuss ongoing investigations of prophylactic anticoagulation in the hopes of improving disease-related outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773799     DOI: 10.6004/jnccn.2012.0087

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  8 in total

Review 1.  Palliative care and advance care planning for pancreas and other cancers.

Authors:  Rajiv Agarwal; Andrew S Epstein
Journal:  Chin Clin Oncol       Date:  2017-06

2.  ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.

Authors:  João Godinho; Mafalda Casa-Nova; João Moreira-Pinto; Pedro Simões; Francisco Paralta Branco; Luísa Leal-Costa; Ana Faria; Fábio Lopes; José Alberto Teixeira; José Luís Passos-Coelho
Journal:  Oncologist       Date:  2019-10-22

3.  Incidental pulmonary embolism in oncology patients with current macroscopic malignancy: incidence in different tumour type and impact of delayed treatment on survival outcome.

Authors:  Maung Maung Myat Moe; Sridhar Redla
Journal:  Br J Radiol       Date:  2018-05-10       Impact factor: 3.039

4.  ONKOTEV Score as a Predictive Tool for Thromboembolic Events in Pancreatic Cancer-A Retrospective Analysis.

Authors:  João Godinho; Mafalda Casa-Nova; João Moreira-Pinto; Pedro Simões; Francisco Paralta Branco; Luísa Leal-Costa; Ana Faria; Fábio Lopes; José Alberto Teixeira; José Luís Passos-Coelho
Journal:  Oncologist       Date:  2019-10-22

Review 5.  Pancreatic cancer-A disease in need: Optimizing and integrating supportive care.

Authors:  Gordon T Moffat; Andrew S Epstein; Eileen M O'Reilly
Journal:  Cancer       Date:  2019-08-05       Impact factor: 6.860

6.  Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience.

Authors:  L Gutierrez-Sainz; V Martinez-Marin; D Viñal; D Martinez-Perez; J Pedregosa; J A Garcia-Cuesta; J Villamayor; P Zamora; A Pinto; A Redondo; B Castelo; P Cruz; O Higuera; A Custodio; A Gallego; D Sanchez-Cabrero; J de Castro-Carpeño; E Espinosa; J Feliu
Journal:  Clin Transl Oncol       Date:  2020-11-24       Impact factor: 3.405

7.  Incidence and risk factors for venous thromboembolism in patients with pretreated advanced pancreatic carcinoma.

Authors:  Shunsuke Kondo; Mitsuhito Sasaki; Hiroko Hosoi; Yasunari Sakamoto; Chigusa Morizane; Hideki Ueno; Takuji Okusaka
Journal:  Oncotarget       Date:  2018-03-30

8.  Early detection of venous thromboembolism after the initiation of chemotherapy predicts a poor prognosis in patients with unresectable metastatic pancreatic cancer who underwent first-line chemotherapy with gemcitabine plus nab-paclitaxel.

Authors:  Takuo Yamai; Kenji Ikezawa; Erika Hiraga; Yasuharu Kawamoto; Takeru Hirao; Sena Higashi; Kazuma Daiku; Shingo Maeda; Yutaro Abe; Makiko Urabe; Yugo Kai; Ryoji Takada; Tasuku Nakabori; Nobuyasu Fukutake; Hiroyuki Uehara; Masashi Fujita; Kazuyoshi Ohkawa
Journal:  PLoS One       Date:  2022-03-01       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.